Harrow, Inc. (HROW)

52.03 +1.21 (+2.38%) USD  |  NASDAQ  |  Feb 20, 16:00
52.03 0.00 (0.00%) After-Hours: 20:00
More

Harrow Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
CapsoVision, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade